Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate
Status:
No longer available
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether anecortave acetate can slow or stop the
progression of age-related macular degeneration in patients who do not qualify for other
studies and have no other treatment options.